Twist Bioscience Corp. (TWST)
140.74
-4.85
(-3.33%)
USD |
NASDAQ |
Aug 24, 16:00
138.00
-2.74
(-1.95%)
After-Hours: 20:00
Twist Bioscience Total Liabilities (Quarterly) : 226.70M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 226.70M |
| March 31, 2026 | 221.12M |
| December 31, 2025 | 181.99M |
| September 30, 2025 | 168.90M |
| June 30, 2025 | 165.41M |
| March 31, 2025 | 155.51M |
| December 31, 2024 | 152.64M |
| September 30, 2024 | 141.63M |
| June 30, 2024 | 146.98M |
| March 31, 2024 | 142.72M |
| December 31, 2023 | 142.77M |
| September 30, 2023 | 152.97M |
| June 30, 2023 | 152.78M |
| March 31, 2023 | 149.99M |
| December 31, 2022 | 163.64M |
| September 30, 2022 | 171.99M |
| June 30, 2022 | 158.99M |
| March 31, 2022 | 158.28M |
| Date | Value |
|---|---|
| December 31, 2021 | 159.99M |
| September 30, 2021 | 121.28M |
| June 30, 2021 | 114.85M |
| March 31, 2021 | 63.11M |
| December 31, 2020 | 61.62M |
| September 30, 2020 | 62.62M |
| June 30, 2020 | 59.29M |
| March 31, 2020 | 59.67M |
| December 31, 2019 | 89.20M |
| September 30, 2019 | 34.91M |
| June 30, 2019 | 30.80M |
| March 31, 2019 | 24.69M |
| December 31, 2018 | 25.86M |
| September 30, 2018 | 26.73M |
| June 30, 2018 | 26.92M |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | 19.38M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 318.91M |
| Prime Medicine, Inc. | 209.23M |
| Intellia Therapeutics, Inc. | 129.46M |
| 10X Genomics, Inc. | 204.52M |
| Generate Biomedicines, Inc. | 105.64M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 672.44M |
| Shareholders Equity (Quarterly) | 445.74M |
| Debt to Equity Ratio | 0.21 |
| Current Ratio | 2.672 |
| Net Debt Paydown Yield | -0.04% |